Under construction – not a live service
Sign in
Taking peopleNo phase

Retro-walking Versus Forward-walking Training Using Underwater Treadmill in Patients With Knee Osteoarthritis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 60 years old?

Source: NCT06896032, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Nourhan Atwa Said
Trial code
NCT06896032
Record updated
16 April 2025
Original description
The purpose of this study Will investigate and compare the effects of retro-walking and forward-walking underwater treadmill training on pain, function and ROM in subjects with chronic knee OARead full original descriptionShow less

Effect of Retro-walking Versus Forward-walking Training Using Underwater Treadmill on Pain and Function in Patients With Knee Osteoarthritis

The purpose of this study Will investigate and compare the effects of retro-walking and forward-walking underwater treadmill training on pain, function and ROM in subjects with chronic knee OA

Inclusion: 60 patients with chronic knee OA; Age ranges from 40-60 years old of both genders; body mass index (BMI) 25- 35kg/m2; The degree of osteoarthritis was mild or moderate and have a Kellgren- Lawrence radiographic grade of of1-3; unilateral knee osteoarthritis involvement.

Exclusion: infection; psychiatric disorder; cardiac pacemaker; systemic inflammatory disease and bone malignancy; hydrophobia; pregnancy; haemorrhagic diathesis; all Subjects with deformity of hip, knee \& ankle; any CNS or PNS involvement; recent steroidal or intraarticular injections (3 months).

ClinicalTrials.gov NCT06896032